The Biosimilar Development Process

U.S. Food and Drug Administration
U.S. Food and Drug Administration
36.1 هزار بار بازدید - 6 سال پیش - FDA’s abbreviated licensure pathway brings
FDA’s abbreviated licensure pathway brings biosimilars into the market sooner, while still ensuring their safety and effectiveness. Learn more with Dr. Sue Lim, M.D., Director at FDA’s Center for Drug Evaluation and Research. For more information, visit https://www.FDA.gov/biosimilars
6 سال پیش در تاریخ 1397/03/01 منتشر شده است.
36,122 بـار بازدید شده
... بیشتر